Riboflavin deficiency and preeclampsia

Obstetrics and Gynecology

Volumn 96, Issue 1, 2000, Pages 38-44

  Wacker, Jürgen ^a   Frühauf, Johannes ^a   Schulz, Michael ^a   Chiwora, Francis M ^d   Volz, Joachim ^c   Becker, Katja ^b  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d Mpilo Hospital   (Zimbabwe)

Author keywords

[No Author keywords available]

Indexed keywords

FLAVINE ADENINE NUCLEOTIDE; GLUTATHIONE REDUCTASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE PREDISPOSITION; ERYTHROCYTE; HIGH RISK POPULATION; HUMAN; PATHOPHYSIOLOGY; PREECLAMPSIA; PRIORITY JOURNAL; RIBOFLAVIN DEFICIENCY; RISK; ZIMBABWE;

ADULT; FEMALE; GLUTATHIONE REDUCTASE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY, HIGH-RISK; PROSPECTIVE STUDIES; RIBOFLAVIN DEFICIENCY; RISK FACTORS; ZIMBABWE;

EID: 0342369342     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(00)00847-4     Document Type: Article

References (41)

1. Roberts J.M., Redman C.W.G. Preeclampsia More than pregnancy-induced hypertension . Lancet. 341:1993;1447-1451.
2. Roberts J.M. Prevention or early treatment of preeclampsia. N Engl J Med. 337:1997;124-125.
3. Dekker G.A., Sibai B.M. Etiology and pathogenesis of preeclampsia Current concepts . Am J Obstet Gynecol. 179:1998;1359-1375.
4. Repke J.T., Robinson J.N. The prevention and management of preeclampsia and eclampsia. Int J Gynaecol Obstet. 62:1998;1-9.
5. Sibai B.M. Prevention of preeclampsia A big disappointment . Am J Obstet Gynecol. 179:1998;1275-1278.
6. Chappell L., Seed P., Briley A., Kelly F., Lee R., Hunt B., et al. Effect of antioxidants on the occurrence of preeclampsia in women at increased risk A randomised trial . Lancet. 354:1999;810-816.
7. Mikhail M.S., Anyaegbunam A., Garfinkel D., Palan P.R., Basu J., Romney S.L. Preeclampsia and antioxidant nutrients Decreased plasma levels of reduced ascorbic acid, α-tocopherol, and β-carotene in women with preeclampsia . Am J Obstet Gynecol. 171:1994;150-157.
8. Wacker J., Schulz M., Frühauf J., Chiwora F.M., Solomayer E., Bastert G. Seasonal change in the incidence of preeclampsia in Zimbabwe. Acta Obstet Gynecol Scand. 77:1998;712-716.
9. Bates C.J., Prentice A.M., Paul A.A., Sutcliffe B.A., Watkinson M., Whitehead R.G. Riboflavin status in Gambian pregnant and lactating women and its implications for recommended daily allowances. Am J Clin Nutr. 34:1981;928-935.
10. Bates C.J. Human riboflavin requirements and metabolic consequences of deficiency in man and animals. World Rev Nutr Diet. 50:1987;215-265.
11. Natraj U., George S., Kadam P. Isolation and partial characterization of human riboflavin carrier protein and the estimation of its level during human pregnancy. J Reprod Immunol. 13:1988;1-7.
12. Becker K., Krebs B., Schirmer R.H. Protein-chemical standardization of the erythrocyte glutathione reductase activation test (EGRAC test). Application to hypothyroidism. Int J Vitam Nutr Res. 61:1991;180-187.
13. Arscott L.D., Gromer S., Schirmer R.H., Becker K., Williams C.H. The mechanism of thioredoxin reductase from human placenta is similar to the mechanisms of lipoamide dehydrogenase and glutathione reductase and is distinct from the mechanism of thioredoxin reductase from Escherichia coli. Proc Natl Acad Sci USA. 94:1997;3621-3626.
14. Brennecke S., Gude N., Di Iulio J., King R. Reduction of placental nitric oxide synthase activity in preeclampsia. Clin Sci. 93:1997;51-55.
15. Munjanja S.P., Lindmark G., Nyström L. Randomized controlled trial of a reduced-visits programme of antenatal care in Harare, Zimbabwe. Lancet. 348:1996;364-369.
16. Becker K., Leichsenring M., Gana L., Bremer H., Schirmer R. Glutathione and associated antioxidant systems in protein energy malnutrition Results of a study in Nigeria . Free Radic Biol Med. 18:1995;257-263.
17. Glatzle D., Weber F., Wiss O. Enzymatic test for the detection of a riboflavin deficiency. NADPH-dependent glutathione reductase of red blood cells and its activation by FAD in vitro. Experientia. 24:1968;1122.
18. Heller S., Salkeld R.M., Körner W.F. Riboflavin status in pregnancy. Am J Clin Nutr. 27:1974;1225-1230.
19. Prentice A.M., Goldberg G.R., Poppitt S.D. Reproductive stresses in undernourished and well-nourished women. Bibl Nutr Dieta. 53:1996;1-10.
20. Adiga P.R., Subramanian S., Rao J., Kumar M. Prospects of riboflavin carrier protein (RCP) as an antifertility vaccine in male and female mammals. Hum Reprod Update. 3:1997;299-300.
21. Bates C.J., Prentice A.M., Paul A.A. Seasonal variations in vitamins A, C, riboflavin and folate intakes and status of pregnant and lactating women in a rural Gambian community Some possible implications . Eur J Clin Nutr. 48:1994;660-668.
22. Pongpaew P., Soawakontha S., Schelp F., Rojsathaporn K., Phonrat B., Vudhivai N., et al. Vitamin B1, B2 and B6 during the course of pregnancy of rural and urban women in northeast Thailand. Int J Vitam Nutr Res. 65:1994;111-116.
23. Aggett N., Van der Westhuyzen J., Kuyl J., Metz J. Monitoring the voluntary fortification of maize meal with riboflavin and nicotinamide. S Afr Med J. 76:1989;342-344.
24. Wang Y., Walsh S., Guo J., Zhang J. The imbalance between thromboxane and prostacycline in preeclampsia is associated with an imbalance between lipid peroxides and vitamin E in maternal blood. Am J Obstet Gynecol. 165:1991;1695-1700.
25. Klimek J., Wozniak M., Szymanska G., Zelewski L. Inhibitory effect of free radicals derived from organic hydroperoxide on progesterone synthesis in human term placental mitochondria. Free Radic Biol Med. 24:1998;1168-1175.
26. Widschwendter M., Schrocksnadel H., Mortl M.G. Pre-eclampsia A disorder of placental mitochondria? Mol Med Today. 4:1998;286-291.
27. Vuorinen K., Remes A., Sormunen R., Tapanainen J., Hassinen I.E. Placental mitochondrial DNA and respiratory chain enzymes in the etiology of preeclampsia. Obstet Gynecol. 91:1998;950-955.
28. Salas S.P. Role of nitric oxide in maternal hemodynamics and hormonal changes in pregnant rats. Biol Res. 31:1998;243-250.
29. Becker K., Savvides S., Keese M., Schirmer R.H., Karplus P.A. Enzyme inactivation by NO carrier-based sulfhydryl oxidation. Nature Struct Biol. 5:1998;267-271.
30. Walsh S.W., Wang Y. Deficient glutathione peroxidase activity in preeclampsia is associated with increased placental production of thromboxane and lipid peroxides. Am J Obstet Gynecol. 169:1993;1456-1461.
31. Walsh S.W., Wang Y. Secretion of lipid peroxides by the human placenta. Am J Obstet Gynecol. 169:1993;1462-1466.
32. Gülmezoglu A.M., Hofmeyr G.J., Oosthuisen M.M.J. Antioxidants in the treatment of severe preeclampsia An explanatory randomized controlled trial . Br J Obstet Gynaecol. 104:1997;689-696.
33. Hirano H., Hamajima S., Horiuchi S., Niitsu Y., Ono S. Effects of B2-deficiency on lipoperoxide and its scavenging system in the rat lens. Int J Vitam Nutr Res. 53:1983;377-382.
34. Torbergsen T., Oian P., Mathiesen E., Borud O. Preeclampsia - a mitochondrial disease? Acta Obstet Gynecol Scand. 68:1989;145-148.
35. Tyni T., Ekholm E., Pihko H. Pregnancy complications are frequent in long chain 3 hydroxyacyl coenzyme A dehydrogenase deficiency. Am J Obstet Gynecol. 178:1998;603-608.
36. Myatt L., Brewer A., Brockman D.E. The action of nitric oxide in the perfused human fetal-placental circulation. Am J Obstet Gynecol. 164:1991;687-692.
37. Pettersson A., Hedner T., Milsom I. Increased circulating concentrations of asymmetric dimethyl arginine (ADMA), an endogenous inhibitor of nitric oxide synthesis, in preeclampsia. Acta Obstet Gynecol Scand. 77:1998;808-813.
38. Leszczynska-Gorzelak B., Oleszczuk J., Kaminski K., Szymula D., Gorzelak M., Oleszczuk J.J. Disturbed nitric oxide/endothelin-1 equilibrium in cultured human placental endotheliocytes in preeclampsia. Gynecol Obstet Invest. 46:1998;145-149.
39. Yallampalli C., Garfield R. Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia. Am J Obstet Gynecol. 169:1993;1316-1320.
40. Nakatsuka M., Tada K., Kimura Y., Asagiri K., Kamada Y., Takata M., et al. Clinical experience of long-term transdermal treatment with nitric oxide donor for women with preeclampsia. Gynecol Obstet Invest. 47:1999;13-19.
41. Myatt L., Brockman D., Langdon G., Pollock J. Constitutive calcium-dependent isoforms of nitric oxide synthase in the human placental villous vascular tree. Placenta. 14:1993;373-383.